Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 20895 [2017-09015]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 85 / Thursday, May 4, 2017 / Notices
20895
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
Administration for Children and
Families
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Submission for OMB Review;
Comment Request
[FR Doc. 2017–09013 Filed 5–3–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
pmangrum on DSK3GDR082PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement,
PS17–005, Strengthening HIV/AIDS
Research in Kenya.
Time and Date: 10:00 a.m.–5:00 p.m.,
EDT, May 24, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Strengthening HIV/AIDS Research in
Kenya’’, PS17–005.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement,
RFA–TS17–001, Identify and
Characterize Potential Environmental
Risk Factors for Amyotrophic Lateral
Sclerosis (ALS).
Time and Date: 8:00 a.m.–5:00 p.m.,
EDT, May 31, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Identify and Characterize Potential
Environmental Risk Factors for ALS’’,
RFA–TS–17–001.
Contact Person for More Information:
Oscar Tarrago, M.D., M.P.H., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341–3724, Telephone: (770)
488–3492.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–09015 Filed 5–3–17; 8:45 am]
Title: Center for States Evaluation
Ancillary Data Collection.
OMB No.: New Collection.
Description: The Evaluation of the
Child Welfare Capacity Building
Collaborative, Center for States is
sponsored by the Children’s Bureau,
Administration for Children and
Families of the U.S. Department of
Health and Human Services. The
purpose of this evaluation is to respond
to a set of cross-cutting evaluation
questions posed by the Children’s
Bureau. This new information collection
is an ancillary part of a larger data
collection effort being conducted for the
evaluation of the Child Welfare Capacity
Building Collaborative. Two groups of
instruments for the larger evaluation
have already been submitted, and
requests for clearance have been
submitted to the Office of Management
and Budget (see Federal Register
Volume 80, No. 211, November 2, 2015;
Federal Register Volume 81, No. 41,
March 2, 2016; Federal Register Volume
81, No. 111, June 9, 2016; Federal
Register Volume 81, No. 186, September
26, 2016), with the first group of
instruments approved on August 31,
2016. This notice details a group of
instruments that are specific only to the
Center for States. The instruments focus
on (1) evaluating an innovative
approach to engaging professionals in
networking and professional
development through virtual
conferences, (2) understanding fidelity
to and effectiveness of the Center for
States’ Capacity Building Model, and (3)
capturing consistent information during
the updated annual assessment process
focused on related contextual issues
impacting potential service delivery
such as implementation of new
legislation.
Respondents: Respondents of these
data collection instruments will include
child welfare agency staff and
stakeholders who directly receive
services.
BILLING CODE 4163–18–P
[FR Doc. 2017–09014 Filed 5–3–17; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
14:39 May 03, 2017
Jkt 241001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 82, Number 85 (Thursday, May 4, 2017)]
[Notices]
[Page 20895]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09015]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement, RFA-TS17-
001, Identify and Characterize Potential Environmental Risk Factors for
Amyotrophic Lateral Sclerosis (ALS).
Time and Date: 8:00 a.m.-5:00 p.m., EDT, May 31, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Identify and Characterize Potential Environmental Risk Factors for
ALS'', RFA-TS-17-001.
Contact Person for More Information: Oscar Tarrago, M.D., M.P.H.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63,
Atlanta, Georgia 30341-3724, Telephone: (770) 488-3492.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-09015 Filed 5-3-17; 8:45 am]
BILLING CODE 4163-18-P
